Repeated administration of tacrine to normal rats: Effects on cholinergic, glutamatergic, and GABAergic receptor subtypes in rat brain using receptor autoradiography

Adem, 1994, A novel anticholinesterase THB013: biochemical and behavioural studies, J. Neural Transm. [P-D Sect.], 8, 139, 10.1007/BF02250925 Albin, 1988, Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site, Neurosci. Lett., 88, 303, 10.1016/0304-3940(88)90228-5 Alonso, 1990, Effects of repeated administration of tetrahydroaminoacridine (THA) on muscarinic receptor subtypes in the rat brain, Neurochem. Int., 17, 457, 10.1016/0197-0186(90)90028-R Bierer, 1995, Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits, J. Neurochem., 64, 749, 10.1046/j.1471-4159.1995.64020749.x Clarke, 1994, Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum, Br. J. Pharmacol., 111, 695, 10.1111/j.1476-5381.1994.tb14793.x Davenport, 1988, Tetrahydroaminoacridine selectively attenuates NMDA receptor mediated neurotoxicity, Eur. J. Pharmacol., 154, 73, 10.1016/0014-2999(88)90365-2 Dawson, 1990, Reversibility of the inhibition of acetylcholinesterase by tacrine, Neurosci. Lett., 118, 85, 10.1016/0304-3940(90)90254-7 Decker, 1991, The role of interactions between cholinergic system and other neuromodulatory systems in learning and memory, Synapse, 7, 151, 10.1002/syn.890070209 Drukarch, 1987, 9-Amino-1,2,3,4-tetrahydroaminoacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K + current, Eur. J. Pharmacol., 141, 153, 10.1016/0014-2999(87)90424-9 Dunnett, 1991, The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions, Trends Neurosci., 14, 494, 10.1016/0166-2236(91)90061-X Dutar, 1990, Effects of tetrahydro-9-aminoacridine on cortical and hippocampal neurons in the rat: an in vivo and in vitro study, Brain Res., 527, 32, 10.1016/0006-8993(90)91057-N Flynn, 1989, Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine, J. Pharmacol. Exp. Ther., 250, 573 Freeman, 1991, Tacrine: a pharmacological review, Progr. Neurobiol., 36, 257, 10.1016/0301-0082(91)90002-I Halliwell, 1989, 9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neurones, Eur. J. Pharmacol., 163, 369, 10.1016/0014-2999(89)90209-4 Heilbronn, 1961, Inhibition of cholinesterase by tetrahydroacridine, Acta Chem. Scand., 15, 1386, 10.3891/acta.chem.scand.15-1386 Hershkowitz, 1991, Tetrahydroaminoacridine block of N-methyl-d-aspartate-activated cation channels in cultured hippocampal neurons, Mol. Pharmacol., 39, 592 Hunter, 1989, The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro, Br. J. Pharmacol., 98, 79, 10.1111/j.1476-5381.1989.tb16865.x Kawashima, 1994, Effects of centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 523, 10.1007/BF00173022 Kiefer-Day, 1993, Effects of tacrine on brain muscarinic-receptor-mediated second-messenger signals, Pharmacology, 47, 98, 10.1159/000139084 Kumar, 1992, Postnatal development of cholinergic receptors, protein kinase C and dihydropyridine-sensitive calcium antagonist binding in rat visual cortex. Effect of visual deprivation, Int. J. Devl. Neurosci., 10, 491, 10.1016/0736-5748(92)90050-A Kumar, 1993, Postnatal ontogeny of GABAA and benzodiazepine receptors in individual layers of rat visual cortex and the effect of visual deprivation, Neurochem. Int., 23, 99, 10.1016/0197-0186(93)90086-K Kumar, 1994, Postnatal development of NMDA, AMPA, and kainate receptors in individual layers of rat visual cortex and the effect of monocular deprivation, Int. J. Devl. Neurosci., 12, 31, 10.1016/0736-5748(94)90093-0 McNally, 1989, Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose, Pharmaceut. Res., 6, 924, 10.1023/A:1015933210803 Messamore, 1993, Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex, Neuropharmacology, 32, 745, 10.1016/0028-3908(93)90182-3 Musilková, 1991, The binding of cholinesterase inhibitors tacrine (tetrahydroaminoacridine) and 7-methoxytacrine to muscarine acetylcholine receptors in rat brain in the presence of eserine, Neurosci. Lett., 125, 113, 10.1016/0304-3940(91)90004-D Nielsen, 1989, Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes, Eur. J. Pharmacol., 173, 53, 10.1016/0014-2999(89)90008-3 Nilsson, 1987, Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?, J. Neural. Transm., 70, 357, 10.1007/BF01253610 Nordberg, 1992, Neuroreceptor changes in Alzheimer disease, Cerebrovasc. Brain Met. Rev., 4, 303 O'Connell, 1994, The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat, Neurochem. Int., 25, 555, 10.1016/0197-0186(94)90154-6 Pearce, 1988, Effects of tetrahydroaminoacridine on M1 and M2 muscarinic receptors, Neurosci. Lett., 88, 281, 10.1016/0304-3940(88)90224-8 Perry, 1988, Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vivo, Neurosci. Lett., 91, 211, 10.1016/0304-3940(88)90770-7 Potter, 1989, Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarinic receptors, Mol. Pharmacol., 35, 652 Rogawski, 1987, Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons, Eur. J. Pharmacol., 142, 169, 10.1016/0014-2999(87)90670-4 Roβner, 1994, Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions, Brain Res., 668, 85, 10.1016/0006-8993(94)90514-2 Roβner, 1995, Differential changes in cholinergic markers from selected brain regions after specific immunolesion of rat cholinergic basal forebrain system, J. Neurosci. Res., 40, 31, 10.1002/jnr.490400105 Roβner, 1995, 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions, Brain Res., 696, 165, 10.1016/0006-8993(95)00844-G Roβner, 1995, 192IgG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus, Brain Res. Bull., 38, 371, 10.1016/0361-9230(95)02002-9 Schauf, 1987, Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola, J. Pharmacol. Exp. Ther., 243, 609 Schliebs, 1994, Receptor function in rat brain regions after lesion of nucleus basalis, J. Neural Transm., Suppl., 44, 195 Schwartz, 1983, Adaptive changes of neurotransmitter receptor mechanisms in the central nervous system, Progr. Brain Res., 58, 117, 10.1016/S0079-6123(08)60012-6 Steckler, 1995, The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour, Behav. Brain Res., 67, 165, 10.1016/0166-4328(94)00157-B Stevens, 1987, Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons, Neurosci. Lett., 79, 301, 10.1016/0304-3940(87)90448-4 Suzuki, 1994, Tacrine increases stimulation-evoked acetylcholine release from rat hippocampal slices, Jpn. Pharmacol., 65, 337, 10.1254/jjp.65.337 Szilagyi, 1993, Interaction of tacrine at M1 and M2 cholinoceptors in guinea pig brain, Pharmacology, 47, 223, 10.1159/000139101 Vivas, 1995, Action on noradrenergic transmission of an anticholinesterase—9-Amino-1,2,3,4-tetrahydroacridine, Neuropharmacology, 34, 367, 10.1016/0028-3908(95)00003-O Vorobjev, 1994, Tetrahydroaminoacridine blocks and prolongs NMDA receptor-mediated responses in a voltage-dependent manner, Eur. J. Pharmacol., 253, 1, 10.1016/0014-2999(94)90750-1 Wagstaff, 1994, Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease, Drugs and Aging, 4, 510, 10.2165/00002512-199404060-00006 Wang, 1995, Tetrahydro-9-aminoacridine presynaptically inhibits glutamatergic transmission in the rat amygdala, Brain Res. Bull., 37, 325, 10.1016/0361-9230(95)00010-C Warpman, 1996, Effect of tacrine on in vivo release of dopamine and its metabolites in the striatum of freely moving rats, J. Pharmacol. Exp. Ther., 277, 917 Xiao, 1993, Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats, J. Pharmacol. Exp. Ther., 265, 759 Zilles, 1985